Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00004778Phase 3Completed
Phase 3, randomised, double-blind trial in respiratory distress syndrome (RDS) and chronic lung disease comparing TRH Group with Placebo Group (2 arms). Primary endpoints: Severity of initial lung disease and Occurrence of chronic lung disease. Started Aug 1993; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00004778.